Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
84
|
| pubmed:dateCreated |
1979-4-26
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0070-4067
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
145-8
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:283634-Adult,
pubmed-meshheading:283634-Cytarabine,
pubmed-meshheading:283634-Daunorubicin,
pubmed-meshheading:283634-Drug Therapy, Combination,
pubmed-meshheading:283634-Humans,
pubmed-meshheading:283634-Ifosfamide,
pubmed-meshheading:283634-Leukemia, Myeloid, Acute,
pubmed-meshheading:283634-Middle Aged,
pubmed-meshheading:283634-Thioguanine
|
| pubmed:year |
1978
|
| pubmed:articleTitle |
[Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
|
| pubmed:publicationType |
Journal Article
|